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Methods and Results: In six patients (mean age 59i7 years) with sever LV dysfunction 
the NES delivery system (Optimizer) was implanted. Three patients had ischemic cardi- 
omyopathy (CM), and 3 with dilated CM. Mean left ventricular ejection fraction and ORS 
duration were 17f4 % and 116i16 ms, respectively. The NES was delivered using two 
bipolar electrodes placed at the right ventricular septum. Halter recording were per- 
formed 2, 3. 4, 5 and 6 weeks on a daily basis post implantMean heart rate (HR), QTc, 
number of premature ventricular tachycardia (PVC), non-sustained ventricular tachycar- 
dia episodes (NSVT), and sustained monomorphic ventricular tachycardia episodes 
(MSVT) were analyzed from 24-hour Halter. Changes in electrocardiographic parametes 
and arrhythmias were compared prior (group a), during (group b) and after (group c) NES 
delivery: 
Group a Group b Grow c 
JACC March 6,2002 
HR 83i14 77*17 60?16 
QTC 403il5 393*17’+ 405zt16 
PVCS 1007i2868 17of421’+ 76011088 
NSVT 12zt26 3*3^+ 10*4 
MSVT 5+4 0 5*3 
* p<O.OOOl comparison with group a; + pcO.0001 comparison with group c 
Conclusion: Non-excitatory signal delivery seems to have an antiarrhyihmic effect in 
patients with severe LV dysfunction by slowing the HR and suppressing ventricular 
arrhythmias. 
1037-I 54 Significance of Atrial Fibrillation in Patients With Acute 
Myocardial Infarction and Symptomatic or 
Asymptomatlc Left Ventricular Dysfunction: Data From 
the OPTIMAAL Study 
&m&me&m, Karl Swedberg, Steve Snappin, for the OPTIMAAL Study Group, 
Sshlgrenska University Hospifa//&tra, G&eborg, Sweden, Merck RL, Whitehouse 
Station, New Jersey 
Background; Atrial fibrillation (AF) is associated with the presence of chemic heart dis- 
ease and/or congestive heart failure (HF). The prognostic importance of AF after myocar- 
dial infarction (Ml) is unclear. 
Methods; The OPTIMAAL Study randomised patients with clinical evidence of HF during 
the acute phase of a Ml, patients with a new anterior Q wave MI, or patients with a re-inf- 
arction in the presence of a previous anterior Q wave MI to treatment with losartan or 
captopril in addition to standard treatment. 
Results; 5477 patients, 71 % males, 67.4 t 9.9 years were included. In 626 patients AF 
was present at baseline while 273 developed AF. 
Total No AF at AF at No AFduring AF during 
population base base studv studv 
Number of patients 5477 4851 626 4578 273 
Age 67.4f9.9 66.7?9.8 73.1f8.6 66.4k9.8 70.5 + 6.7 
p< 0.001 p< 0.001 
ular arrhythmic events were found. 
DISCUSSION: The results of the present study suggest that increased ET-1 concentra- 
tions may be involved in promoting the occurrence of ventricular anhythmic events in CHF 
patients. Proarrhythmic effects may account. in part, for the pow outcome associated with 
increased ET-1 levels in patients with left ventricular dysfunction. 
1037-156 Benefit of Slowing the Ventricular Rate for Left 
Ventricular Systolic Performance During Atrial 
Flbrlllatlon in Subjects With Myocardlal Infarction 
BTabata, Richard A. Grimm, Yongjin Kim, Junko Watanabe, Neil L. Greenberg, 
Deborah D. Agler, Youhua Zhang, Shaowei Zhuang, Don W. Wallick. Kent A. Mowrey, 
Todor N. Mazgalev, Takashi Oki, James D. Thomas, The University of Tokushima, 
Tokushfma. Japan, The Cleveland Clinic Foundation, Cleveland, Ohio. 
Background: Slowing ventricular rate during atrial fibrillation (AF) by post-ganglionic 
vagal nerve stimulation (PGVS) is expected to improve left ventricular (LV) systolic per- 
formance in coronary artery disease. We reported that LV systolic parameters during AF 
correlated well with the ratio of preceding and pre-preceding RR intervals (RR,/RR& 
and the value at RR,/RR, = 1 in the linear regression line could estimate LV systolic func- 
tion in lone AF. 
Purpose: We evaluated the effect of ventricular rate slowing by PGVS on LV systolic 
function in a canine myocardial infarction (MI) and AF model using this index. 
Methods: Data were obtained in 8 healthy mongrel dogs at baseline sinus rhythm (N- 
SR). Ml was created by ligating left anterior descending coronary artery (MI-SR). AF was 
triggered (MI-AF) and PGVS was subsequently applied (MI-PGVS). LV systolic function 
was estimated by max dP/dt and aortic peak flow rate (AoF) during AF using RR,/RR, = 
1 index. 
Results: 1) LV systolic function during sinus rhythm deteriorated after coronary ligation 
and further worsened by AF. 2) RR interval was significantly shortened by AF (530 to 404 
msec) and prolonged by PGVS (547 msec). 3) Max dP/dt and AoF significantly 
decreased by AF and increased by PGVS. 
Conctuslon: 1) Slowing ventricular rate by PGVS during AF improved LV systolic perfor- 
mance in the subjects with coronary artery disease. 2) The systolic parameters at RR,/ 
RR, = 1 accurately evaluated LV systolic function during AF even in impaired ventricles. 
N-SR MI-SR MI-AF MI-PGVS 
Max dP/dt (mm Hg) 3429zt213 2409+612 1979i747 23891661 
AoF (Umin) 11.6* 1.7 8.6 ?z 2.1 5.5+ 1.5 7.5 f 2.4 
1037-l 57 Effects of Sauna Therapy on Cardiac Arrhythmia in 
Patients With Chronic Heart Failure 
Takashl m, Sadatoshi Biro, Masakazu Imamura, Shiro Yoshifuku, Kunitsugu 
Takasaki, Yutaka Otsuji. Yoshifumi Toyama, Shinichi Minagoe, Chuwa Tei, Faculty of 
Medicine, Kagoshima University. Kagoshima, Japan, Nampuh hospital, Kagoshima, 
Japan. 
Background: We have previously reported that repeated 60 degree C dry sauna bathing, 
a thenal therapy, improves hemodynamics and clinical symptoms in patients with 
Signs of HF at base, % 68 67 82 66 74 chronic heart failure (CHF). Since cardiac arrhythmia is an important target in the treat- 
Patients with AF at randomisation had a Hazard Ratio (HR) for death of 2.1 (p < 0.001) 
ment of CHF, we investigated the effects of thermal therapy on cardiac arrhythmia. 
and stroke of 2.1 (p < 0.001) respectively, compared to patients without AF. Development 
Patients and Methods: Twenty six patients with CHF (59il6 years) with NYHA functional 
of AF at any time (pre-randomisation or during the trial) was associated with a HR of 2.6 
class II or III and at least 200 premature ventricular contractions (PVCs) I 24hrs were 
(p< 0.001) for death and 2.5 (pcO.001) for stroke. 
studied. Their medication had not been changed for at least 2 weeks before and during 
Conclusion; In patients with acute Ml and LV-dysfunction with or without HF those who 
the study. They had 60 degree C far infrared-ray dry sauna for 15 min and were kept at 
had AF or developed AF, were older and HF was more prevalent. Both the presence of 
bed rest with blankets for 30 min once a day. Before and at the day after P-week sauna 
AF at baseline and the development of AF during the study are associated with an 
therapy, the effect of the sauna was evaluated with 24-hour Halter recordings for arrhyth- 
adverse prognosis after acute Ml. 
mia and heart rate variability (HRV), chest X-ray and measurement of plasma brain natri- 
uretic peptide (BNP) concentration. Results: All patients enrolled in the study completed 
1037-I 55 Ventricular Arrhythmias in &compensated Heart 
Failure: Role of Endothelin 
wAronson, Darlene P. Horton, Andrew J. Burger, Rambam Medical Center, Haifa, 
Israel, Seth Israel Deaconess Hospital, Boston, Massachusetts. 
INTRODUCTION: Patients with congestive heart failure (CHF) have a high incidence of 
ventricular atiythmias and sudden arrhythmic death. Endothelin-1 (ET-l), a potent vaso- 
constrictor, is elevated in patients with CHF and has been implicated as an important medi- 
ator of increased cardiac filling pressures, pulmonary hypertension, and the progression of 
circulatory failure. Animal studies suggest that ET-1 may be proarrhythmic (Cardiovasc 
Res 2001;49:272-2&l), but whether ET-1 contributes to arrhythmias in human CHF is not 
known. 
METHODS: We studied 83 patients admitted to the hospital for treatment of decompen- 
sated CHF. Neurohormonal and cytokine activation was assessed by measuring plasma 
renin activity, aldosterone. norepinephrine, ET-l, tumor necrosis factor-alpha, and interleu- 
kin-6 levels. Ventricular anhythmic events were assessed by 24-hour Halter monitoring. 
RESULTS: A moderate, but highly significant, positive relation was found between plasma 
ET-1 levels and the average hourly total premature ventricular beats (r = 0.33, p = 0.003), 
the frequency of ventricular pairs (r = 0.39, p = 0.0003), and the frequency of ventricular 
tachycardia episodes (r = 0.35, p = 0.001). 
To exclude possible effects of clinical variables, drug effects. neurohormones. and cytok- 
ines on the relation between ET-l and ventricular ectopic activity, multiple linear regression 
analyses were performed using measures of ventricular ectopy as dependent variables. In 
a multivariate regression analysis, the positive relationship between plasma ET-I level and 
the average hourly total premature ventricular beats (p = O.OQS), the frequency of ventricu- 
lar pairs (p = 0.007). and ventricular tachycardia episodes (p = 0.009) remained significant 
and independent. No assxiations between other neurohormones or cytokines and ventric- 
it. No patient experienced dyspnea, angina pectoris, or palpitations during sa;na bathing. 
Body weight and hematocrit did not change after P-week sauna treatment (53t12 to 
53*12 kg, 38*5 to 37i5 %, respectively). After P-week sauna therapy, 1) PVCs I24hrs 
decreased significantly compared with baseline value (2993*905 to 1476i592 /24hrs, 
PcO.Ol), 2) HRV significantly increased compared with baseline value (9.2il.4 to 
11.6i2.4, PcO.05) in 15 patients without atrial fibrillation (At), however mean heart rate 
did not change, 3) in two of 11 patients with Af sustained for at least 4 days, Af was con- 
verted to sinus rhythm. Plasma BNP concentrations and cardio-thoracic ratios signifi- 
cantly decreased in comparison with baseline value (514i141 to 204292 pglml. PcO.01, 
60+2 to 57+%. P<O.Ol, respectively). Conclusion: Sauna therapy decreases cardiac 
arrhythmia in patients with chronic heart failure, probably due to improvement of cardiac 
function and autonomic nerve function. 
1037- 158 Polygenic Risk Assessment Improves Usefulness of 
Genotyplng in Heart Failure Populations: Additive 
Effects of ACE and eNOS Polymorphisms 
Dennis M. McNama, Richard Holubkov, Lisa A. Postava, Amy Palmer, Karen Janosko, 
Guy A. MacGowan, Michael A. Math@ Srinivas Murali, Arthur M. Feldman, Barry 
London, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. 
Background: Genetic risk assessment that combines data on multiple genes may be a 
more powerful prognostic tool than single gene strategies. The angiotensin convening 
enzyme deletion polymorphism (ACE D) and the endothelial nitric oxide synthase 
Asp298 variant (eNOS T) both adversely influence heart failure survival. We evaluated 
the prognostic value of an analysis which combined eNOS and ACE genotype data in a 
study of heart failure patients. 
Method:463 patients (mean age 55.6 + 12. 49% ischemic, 71% male) referred to the 
Cardiomyopathy Clinic at the University of Pinsburgh with an LVEFS 0.45 were enrolled, 
